Global Healthcare Contract Research Outsourcing Market size is expected to be worth around US$ 100.9 billion by 2033 from US$ 50.8 billion in 2023 ...

Makers of drugs and medical devices say the tariffs on goods from Canada, Mexico and China could have an outsized impact on ...

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

The evolution of protocol management within eQMS represents another significant advance in clinical trials. Version control ...

IQVIA Holdings Inc. (NYSE:IQV) engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe ...

Wade. In order to determine patient interest in permanent contraception, the researchers used health data from IQVIA, a clinical research service, which broke down visits where patients inquired about ...

Could you discuss the key outcomes from the ARCHWAY trial for PDS? The PDS Q24W was noninferior to monthly ranibizumab in terms of BCVA change from baseline ...

Health tech company Inato developed an AI-powered patient prescreening tool to make it easier and faster for research sites to assess patient eligibility for clinical trial opportunities.

It additionally bodes to improve patient retention and site cooperation while speeding up trials to get drugs to market quicker. Arena International’s Outsourcing in Clinical Trials (OCT) West Coast ...

For more information about Insilico's clinical trials please visit ClinicalTrials.gov (NCT06566079). We are pleased to announce the dosing of the first patient in our Phase I ISM6331 clinical ...

12 The goal of developing treatments faster while exposing fewer patients to the risks and burdens of clinical trials is laudable; however, the use of surrogates introduces uncertainty and requires ...

The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) has cleared Pheno Therapeutics to initiate a first-in-human Phase 1 clinical trial to test its oral candidate PTD802 in ...